What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews.
about
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 studyGlobal epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsUtilizing buprenorphine-naloxone to treat illicit and prescription-opioid dependenceGlobal, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Prenatal IV Cocaine: Alterations in Auditory Information ProcessingResponse to Hser et al. (2014): The necessity for more and better data on the global epidemiology of opioid dependence.Internet search and krokodil in the Russian Federation: an infoveillance studyMarijuana use and risk of lung cancer: a 40-year cohort study.New developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010.Maintenance medication for opiate addiction: the foundation of recovery.Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney 293 cells coexpressing κ-, μ-opioid and nociceptin receptors.Development and psychometric validation of a scoring questionnaire to assess healthy lifestyles among adolescents in Catalonia.Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective StudyAnxiety disorders and drug dependence: evidence on sequence and specificity among adultsAn Australian twin study of cannabis and other illicit drug use and misuse, and other psychopathology.Problem drug use prevalence estimation revisited: heterogeneity in capture-recapture and the role of external evidence.ANKK1, TTC12, and NCAM1 polymorphisms and heroin dependence: importance of considering drug exposure.Relationship between Healthy Lifestyle and Sociodemographic Factors in Adolescents in Catalonia: Application of VISA-TEEN Questionnaire.Prenatal cocaine exposure alters progenitor cell markers in the subventricular zone of the adult rat brainNon-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world?The adverse health effects of chronic cannabis use.Drugs currently in Phase II clinical trials for cocaine addiction.Global statistics on addictive behaviours: 2014 status report.Illicit Drug Use Among Gym-Goers: a Cross-sectional Study of Gym-Goers in Sweden.How should prevalence of alcohol use disorders be assessed globally?Social-demographic shift in drug users at the first-ever- methadone maintenance treatment in Wuhan, China.Pattern and characteristics of ecstasy and related drug (ERD) presentations at two hospital emergency departments, Melbourne, Australia, 2008-2010.Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the Iranian Mental Health Survey.Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up.A heavy burden on young minds: the global burden of mental and substance use disorders in children and youth.Illicit drug use and HIV risk in the Dominican Republic: tourism areas create drug use opportunities.Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studies.The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study.Stimulant use disorders: characteristics and comorbidity in an Australian population sample.The Global Burden of Disease projects: what have we learned about illicit drug use and dependence and their contribution to the global burden of disease?Recreational drugs of abuse.Neuroethical issues in pharmacological cognitive enhancement.Substance use and suicide risk in a sample of young Colombian adults: An exploration of psychosocial factors.
P2860
Q21132482-8ACD6C94-088E-4F07-ACF1-B9B954BABF9CQ24630669-810D4028-7EBD-406A-A1DC-425A9C27E38DQ26865674-11CEB901-E32E-4E20-8C56-21072D4F64C7Q28083357-9D8F30C5-8191-4B04-A988-4BC51F58C0DAQ30474856-74949734-9092-4519-8D95-61FAA2067055Q30837336-C7C3AD47-B86F-4595-BF7A-2093E4ECBF93Q34268308-B6B777D0-B9DF-4189-A521-EE9C22536998Q34356964-A5035742-DF46-41BF-91CF-9F2A03D6875AQ34952233-5F7ADB5A-8AB3-4B2F-9A23-5D5D70ADDB82Q35058736-DC9DE405-7BB8-4CCC-B51D-8010392B1564Q35138239-310B7844-C828-498B-B3D4-04BB3DDB0EDEQ36138164-7F104FF8-2FFB-4CDF-B52D-EFEF72293FBBQ36232833-A0BF9163-F44D-4157-9906-75F0B3A36B05Q36517593-CE1197EA-AE6E-4F39-8772-4067C81FAAABQ36567126-92762F3E-7C87-4DC6-A26D-A14ADBD2F5FBQ36982133-0046933D-8D4A-4BC2-A31A-F1570533863AQ37030032-2BCDB5A1-FC85-4975-87F4-8C8527BB3159Q37169169-C49C4FD1-9356-4C95-B1DB-AD1EF82DF837Q37212865-704EE276-EEF4-4228-9F91-6EE03D420EFFQ37296957-22161D9C-2519-42E5-9B05-3C497B9B66DFQ37301119-7FE8A7F2-7D4F-45D4-A526-6A3C15851DC2Q38108385-3D2B8EF3-BA0A-4FA2-ADB6-CC4C2C23EC2BQ38120221-BDB17856-2DB5-43DA-92E9-31171B81A654Q38207705-2FDABC6B-FBC1-4CD2-BBCC-946C3DC54C51Q38474045-FA73F97B-F59A-4F39-8B7D-699805D7B802Q38602616-C6EE7838-08A4-411F-9971-B4662267E45BQ39805863-F62F5472-B6AF-4DF5-9E5A-9F53E8D44248Q40042274-4CEC5F7D-3BB9-4347-9429-E53E207A4B98Q40091993-55863096-7967-4C00-9DEB-42CF694F5764Q40755210-E0DFDD51-490C-43DF-A744-5607DAF0A8DEQ41546234-BFC1265A-750A-4884-B07D-9406B57B2128Q41585578-CEEF57F9-374A-41A6-AB64-4E437B0E7463Q41695020-5813BC3E-85BC-48F9-B35E-2059D5F33EF9Q43075885-6B0BA16D-924F-4903-AA12-CF7565074BE3Q44344114-9EC9B962-04FD-435C-8B40-03A34543882FQ44565831-3B37565F-08C5-4472-94B3-91441D5632BEQ45187194-3B97866A-5843-49D3-87DF-EC6893788196Q46008325-E226C936-9A81-4F85-86C1-144BA9A4DFD4Q47620390-E5018C47-56E6-4FE0-822C-BBC2A617AF13Q47736611-39A1BD26-3C86-453F-84A7-6CC63BA9A062
P2860
What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
What data are available on the ...... ts of four systematic reviews.
@ast
What data are available on the ...... ts of four systematic reviews.
@en
type
label
What data are available on the ...... ts of four systematic reviews.
@ast
What data are available on the ...... ts of four systematic reviews.
@en
prefLabel
What data are available on the ...... ts of four systematic reviews.
@ast
What data are available on the ...... ts of four systematic reviews.
@en
P2093
P50
P1476
What data are available on the ...... ts of four systematic reviews.
@en
P2093
Anna Roberts
Chiara Bucello
Christina Briegleb
GBD illicit drug use writing group
Jennifer McLaren
Johanna Thomas
Lucas Wiessing
Nico Clark
Paul Nelson
P304
P356
10.1016/J.DRUGALCDEP.2010.11.032
P407
P577
2011-03-05T00:00:00Z